Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2)
Switching from one infliximab biosimilar ({CT}-P13) to another infliximab biosimilar ({SB}2) in patients with chronic plaque psoriasis
P. Gisondi;C. Virga;A. Meneguzzo;G. Girolomoni
2020-01-01
Abstract
Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
